Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs
Abstract Recently, research has focused on targeting the oxidative and metabolic vulnerabilities in cancer cells. Natural compounds like curcumin that target such susceptibilities have failed further clinical advancements due to the poor stability and bioavailability as well as the need of high effe...
Guardado en:
Autores principales: | Christopher Pignanelli, Dennis Ma, Megan Noel, Jesse Ropat, Fadi Mansour, Colin Curran, Simon Pupulin, Kristen Larocque, Jianzhang Wu, Guang Liang, Yi Wang, Siyaram Pandey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/541280dca3a14ddc9144ea845137126b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monocarbonyl Analogs of Curcumin Based on the Pseudopelletierine Scaffold: Synthesis and Anti-Inflammatory Activity
por: Damian Pawelski, et al.
Publicado: (2021) -
Synthesis, Molecular Docking, and Evaluation of Some New Curcumin Analogs as Antimalarial Agents
por: Endang Astuti, et al.
Publicado: (2021) -
FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis
por: Eckert J, et al.
Publicado: (2017) -
Autophagy and apoptosis in hepatocellular carcinoma induced by EF25-(GSH)2: a novel curcumin analog.
por: Tao Zhou, et al.
Publicado: (2014) -
The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells
por: Abdelhabib Semlali, et al.
Publicado: (2021)